Auction result of Treasury Bonds – RIKB 27 0415 – RIKB 35 0917Auction result of Treasury Bonds – RIKB 27 0415 – RIKB 35 0917 GlobeNewswire
||
Series RIKB 27 0415RIKB 35 0917Settlement Date 01/15/202501/15/2025Total Amount Allocated (MM) 6,7486,122All Bids Awarded At (Price / Yield) 100.660/7.640102.970/6.600Total Number of Bids Received 3732Total Amount of All Bids Received (MM) 8,7486,872Total Number of Successful Bids 3127Number... 
Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz GlobeNewswire
||
BEDMINSTER, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today... Form 8.5 (EPT/RI) – Brand Architekts Group plcForm 8.5 (EPT/RI) – Brand Architekts Group plc GlobeNewswire
||
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY... Form 8.5 (EPT/RI) – Warpaint London PlcForm 8.5 (EPT/RI) – Warpaint London Plc GlobeNewswire
||
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY... Form 8.5 (EPT/RI) – Poolbeg Pharma PlcForm 8.5 (EPT/RI) – Poolbeg Pharma Plc GlobeNewswire
||
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY... 
Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026 GlobeNewswire
||
– DYNE-101 in DM1: Dyne plans to initiate global Registrational Expansion Cohort of ACHIEVE trial with registrational dose of 6.8 mg/kg Q8W following study data showing splicing correction and... 
MLove’s Rangers Series Shines at CES 2025, Redefining Music ExperiencesMLove’s Rangers Series Shines at CES 2025, Redefining Music Experiences PR Newswire
||
LAS VEGAS, Jan. 10, 2025 /PRNewswire/ — MLove, a leading audio brand, made a stunning appearance at the prestigious Consumer Electronics Show 2025, unveiling its groundbreaking Rangers series of... 
HTX 2025 Outlook: Five Sectors to Look Forward to, and How Trump’s Policy Will Affect Crypto IndustryHTX 2025 Outlook: Five Sectors to Look Forward to, and How Trump’s Policy Will Affect Crypto Industry PR Newswire
||
SINGAPORE, Jan. 10, 2025 /PRNewswire/ — The year 2024 marks a significant chapter in the history of the crypto industry, where we witnessed continuous breakthroughs in blockchain technology, surges... HSBC Bank Plc – Form 8.5 (EPT/RI) – Team Internet Group plcHSBC Bank Plc – Form 8.5 (EPT/RI) – Team Internet Group plc GlobeNewswire
||
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. ... Dimensional Fund Advisors Ltd. : Form 8.3 – HARGREAVES LANSDOWN PLC – Ordinary SharesDimensional Fund Advisors Ltd. : Form 8.3 – HARGREAVES LANSDOWN PLC – Ordinary Shares GlobeNewswire
||
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full...